We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

AOAC Extends Comment Period for Its Proposed Mycotoxin and E.coli Testing Methods

Any lab analyst with a view on how mycotoxins and E.coli bacteria should be screened for in cannabis samples has been invited to comment on AOAC International’s own drafted methods.

Read More

After-hours Cannabis Use Has No Impact on Work Performance, Survey Finds

A new study has partly challenged the notion that cannabis can worsen a worker’s performance.

Read More

Medical Marijuana Leads to Fewer Hospitalizations in Sickle Cell Disease Study

The patients were also more likely to use edible cannabis products compared with inhaled products.

Read More

Cannabis Pre-rolls Recalled in Michigan After Worker Allegedly Licks One

Officials from Michigan’s Marijuana Regulatory Agency (MRA) have recalled nearly 3,200 pre-rolled cannabis cigarettes from 14 retail locations across the state following a “confirmed complaint regarding pre-rolls contaminated with human saliva.”

Read More

Independent Lab Group Calls for Cannabis Testing Reforms in California

"There is no need for the world’s largest cannabis market to make these same mistakes," Antonio Frazier, a board member of the American Council of Independent Laboratories, tells Analytical Cannabis.

Read More

Cannabis Use May Risk Cardiovascular Health, Says American Heart Association

While cannabis may have useful applications in some areas of medicine, cardiovascular health may not be one of them, according to the American Heart Association.

Read More

Europe’s Largest Medical Cannabis Trial Has Begun

Project Twenty21, a two-year-long medical cannabis research project in the UK, has gone live.

Read More

US Cannabis Research Is Still Hindered, So What Regulatory Changes Do Scientists Want to See?

Current federal regulations still tie the hands of many researchers who wish to study the effects of cannabis. So what needs to change?

Read More

FDA Approves Epidiolex to Treat Seizures From Tuberous Sclerosis

The cannabis-derived oral spray can now be prescribed for seizures associated with tuberous sclerosis complex (TCS), a rare genetic condition that causes benign tumors to develop in different parts of the body.

Read More

 
Advertisement